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Abstract
Background: Migraine is a significant health problem, especially for the young people, due to its frequency and
accompanying morbidity, causing disability and loss of performance. In this study, our aim was to determine the
prevalence of migraine headaches among university students in Edirne, a Turkish city.
Methods: In this cross-sectional and descriptive study, study population was composed of students registered to
Trakya University in the academic year of 2008-2009. Out of these, 3694 of them accepted to participate.
Participants who had two or more headaches in the last 3 months formed the headache group. Afterwards, two
preliminary questions were applied to the headache group and participants with at least one affirmative response
were asked to perform the validated ID-Migraine™ test.
Results: The mean age of 3694 students participated in the study was 19.23 ± 1.84 (17-39 years), with adolescents:
adult ratio being 2.5:1. 1613 students (43.7%) did have at least two headaches in the last three months. Migraine-
type headache was detected in 266 subjects (7.2%) based on the ID-Migraine™ test. Of the migraine group, 72
were male (27.1%) and 194 were female (72.9%). There was no significant difference in migraine prevalence
between adolescent and adult age groups.
Conclusions: With a prevalence similar to adults, primary care physicians should be aware of the probability of
migraine headaches in university students in order to maintain a successful school performance.
Background
Migraine is an important health problem that affects more
than 10% of the general population [1-3]. There are var-
ious prevalence rates of migraine type headaches. The
variety of prevalence in different studies depends on the
method used to diagnose migraine-type headaches. In the
first nationwide cross-sectional study, the headache profile
of Turkey has been revealed and the life-time migraine
prevalence of migraine type headaches was reported to be
16%, which was 10.9% in men and 21.8% in women [4].
There are few studies focused on the prevalence of
migraine in university students in Turkey [5-7]. Due to its
negative effects on quality of life, it becomes especially
considerable among university students, who require con-
stant concentration and performance [8,9]. Headaches
have a profound impact on school performance among
university students. This impact is more evident among
migrainous students than students with episodic tension-
type headaches (ETTH) with a 62.7% decrease in capacity
versus 24.4% respectively. Moreover, students with
migraine type headaches missed more school than
students with ETTH [8]. These findings reveal the impor-
tance of migraine headaches in university students. To be
able to determine the prevalence, useful, reliable and vali-
dated screening tests must be applied to such large popu-
lations. Identity Migraine (ID Migraine™) test is a proper
and useful screening tool, developed and validated by
Lipton et al. [10,11], which can be applied quickly to large
numbers of populations. Sensitivity, specificity and positive
predictive value of this test in primary care have been
defined as 81%, 75% and 93%, respectively [11]. The vali-
dation of ID Migraine™ test in Turkish has been made by
Karli with a sensitivity of 91.8%, specificity of 63.4%, posi-
tive predictive value of 71.9% and a negative predictive
value of 88.4% [12]. As World Health Organization
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any medium, provided the original work is properly cited.(WHO) defines adolescence as young people between the
ages of 10 and 19 years, university population consists of
both adolescents and adults. The test is also validated to
be used among adolescent students with a sensitivity of
62.1% and specificity of 71.1% [13]. In this study, we
aimed to determine the prevalence of migraine headaches
among university students using the quick screening tool
ID Migraine™ test.
Methods
In 2008-2009 academic year, 4645 students registered to
different faculties of Trakya University, Edirne, has been
reached and asked to participate in the study. Of the
registrants, 3732 students agreed to participate and filled
out the questionnaire. The study was conducted in accor-
dance with the Declaration of Helsinki and Good Clinical
Practice Guidelines and approved by the institutional
review board. Participants were informed and their verbal
consent was obtained. After the data collection, 3694 par-
ticipants were included in the study. The rest were
excluded due to incomplete questionnaire or inconsistent
responses.
A stepwise evaluation is used to determine the preva-
lence of migraine type headache. Students who replied
“yes” to the first question “Did you have two or more
headaches in the last 3 months?” were considered as the
subjects with headache and asked the preliminary ques-
tions. Participants giving one positive response out of two
were considered as the subjects who are likely to have
migraine type headaches and asked the 3- item ID
Migraine™ test. Subjects with two positive responses out
of those three were considered having migraine headache
(Figure 1).
For the statistical analysis of the cross-sectional,
descriptive study, Statistical Package for the Social
Sciences (SPSS) for Windows was used.
Results
At the end of the study, data collected from 3694 partici-
pants were analyzed. Of the participants, 50.1% were male
(n = 1850) and 49.9% female (n = 1844). The mean age of
the participants was 19.23 ± 1.84, ranging from 17 to
37 years of age (Figure 2). 1613 students (43.7%) who
replied “yes” to the question “Did you have two or more
headaches in the last 3 months?” formed the headache
group. Of the headache group, 43.8% were male (n = 706)
and 56.2% female (n = 907). Female participants had sig-
nificantly higher headache rates than male ones (Pearson
c
2 = 45.628, p < 0.001). Details are shown in Table 1.
As preliminary questions were analyzed, 815 partici-
pants of the headache group (50.5%) had at least one
positive response. 463 participants (28.7%) had “ad e s i r e
to talk to a healthcare professional about this headaches”,
and 633 participants expressed that “his/her ability to
work, study or enjoy life was limited” (39.2%).
This group of participants was further evaluated in
terms of migraine type headaches with application of the
3-item ID Migraine™ test. Of this group, 32.6% (n =
266) gave at least two positive responses and had positive
ID Migraine™ t e s t s .T h ep r e v a l e n c eo fm i g r a i n ea m o n g
all participants according to ID Migraine™ test was 7.2%.
Of the migraine group, 72 were male (27.1%) and 194
were female (72.9%). The rate of migraine in female par-
ticipants was found to be significantly higher than male
ones (Pearson c
2 = 60.725, p < 0.001). The mean age of
the participants with migraine was 19.35 ± 1.84, ranging
from 17 to 29 years of age. There was no statistical signif-
icance between the ages of participants and migraine
prevalence (Pearson c
2 = 16.958, p = 0.593). Of the parti-
cipants, 71.3% (n = 2633) were in the adolescent age,
whereas 28.7% (n = 1061) were in the adult group, with a
ratio of 2.5:1. In comparison, there was no significant dif-
ference between adolescent and adult age groups con-
cerning the migraine rates (7.0% and 7.8%, respectively)
(Table 2). In addition, Table 3 shows the prevalence rates
according to gender and age.
In the migraine group (n = 266), 3 item ID Migraine™
test showed that 75.2% of the participants (n = 200) “felt
nauseated or sick to the stomach”, 86.8% of the partici-
pants (n = 231) were “bothered by light (a lot more than
when they don’t have headaches)”, and 72.9% (n = 194)
expressed that “their headaches limited their ability to
work, study or do what they needed to do for at least one
day”.
Discussion
This study has been conducted among adolescents and
adults registered to different faculties of Trakya Univer-
s i t y ,E d i r n e ,T u r k e y .I DM i g r a i n e ™ test has been used
for screening migraine type headaches. ID Migraine™
test showed that, 7.2% (n = 266) of the 3694 students
had migraine type headache.
The prevalence of migraine is reported to be the high-
est between ages 30-39 [1,4]. However it is also frequent
among adolescents and university students [13]. Age did
not have a relationship with the prevalence of migraine
in our study. There was also no significant difference
between adolescent and adult populations. Thus, the
young people, often thought of as a healthy group, should
not be parted from adults in terms of migraine type
headaches. There are few studies focusing on migraine
among university students in Turkey showing differences
in prevalence. Demirkiran reported a prevalence of 12.4%
among 1029 students, whereas Bicakci reported 21.9%
among 1256 students [5,7]. Kurt found that 17.9% of
2023 students had migraine-type headache [14]. Several
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prevalence of migraine among university students is
reported to be 8.9% in a Croatian study among 314 stu-
dents, 7.0% in a Norwegian study among 5847 students,
and 6.4% in a Nigerian study among 376 students
[15-17]. We found the prevalence of migraine headaches
relatively lower than Turkish, but similar to international
studies. Our relatively larger study population could have
an effect on the results. As the screening test is based on
the presence of headache in the last three months, the
time of the study can also be a limitation factor, which
differs with various studies. A study conducted in more
stressful periods like midterms or final examinations
would have revealed a higher prevalence of migraine
headaches. Also, the methods used to determine the pre-
valence of migraine type headaches can significantly
 
    
 
 
  
    
 
 
 
 
 
   
 
 
 
 
 
 
STEP 1: 
Data collection and application of 
inclusion and exclusion criteria 
STEP 2: 
Determination of headache group: 
 
Did you have two or more headaches in 
the last 3 months? 
 
STEP 3: 
Determination of probability of 
migraine type headache: preliminary 
questions 
 
1. Do you have headaches that limit 
your ability to work, study or enjoy life? 
2. Do you want to talk to your 
healthcare professional about your 
headaches? 
 
STEP 4: 
Determination of migraine type 
headache: 
Ask the three items of ID-Migraine test: 
 
During the last 3 months, did you have 
the following with your headaches? 
1. You felt nauseated or sick to your 
stomach 
2. Light bothered you (a lot more than 
when you don’t have headaches)  
3. Your headaches limited your ability 
to work, study or do what you needed to 
do for at least one day  
 
Inconsistent data and unsuitability 
to inclusion criteria: 
 
EXCLUDE FROM THE STUDY 
Consistent data and suitability to 
inclusion criteria: 
 
GO TO STEP 2 
If YES 
 
GO TO STEP 3 
If NO 
 
EXCLUDE FROM HEADACHE 
GROUP 
If answer is YES to at least one of 
the questions: 
 
GO TO STEP 4 
If answer is NO to both of the 
questions: 
 
Probably not migraine headache 
If answer is YES to at least two of 
the questions: 
 
DIAGNOSE AS MIGRAINE 
HEADACHE 
If answer is NO to at least two of 
the questions: 
 
DIAGNOSE AS NON-
MIGRAINOUS HEADACHE 
Figure 1 Flow-chart of the study process.
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observed in the epidemiological studies. Fewer studies
are present using the validated ID Migraine™ test with
only one similar study population, which is performed in
southern Turkey by Bicakci et al. [7,10-13].
The female/male ratio was 2.7:1 (194/72) in our study,
whereas in two other cities in Turkey, it was 3.4:1 in
Afyon and 1.2:1 in Adana [5,7]. It is compatible with the
literature, as it is known that migraine is more common
in female than male gender [18,19].
The importance of migraine headaches among univer-
sity students lies within its disability potential [20,21]. ID
Migraine™ test items investigate the major aspects of
migraine type headaches, which are nausea, photophobia
and disability. Of the participants, 72.9% (n = 194)
experienced limitation of ability to work or study for at
least one day, whereas 75.2% of the participants (n = 200)
had nausea, 86.8% of the participants (n = 231) had
photophobia. Along with the discomfort caused by the
headache, these results show a significant limitation of
daily routine. As university curriculum requires constant
concentration and hard work, even a one-day absence of
the student can affect his/her school success. Combined
with the fact that there are also 1347 students (36.4%)
having non-migraine headaches, evaluating and mana-
ging headaches among university students become espe-
cially important.
Although there is a previous study among university
students using ID-Migraine test in a different geographi-
cal region of Turkey, we think that our research is use-
ful as it confirms the opportunity to evaluate migraine
prevalence in a population where the disease could exert
a relevant negative impact [7].
Conclusions
Although migraine is thought to be an adult condition,
it is common among adolescents as well. It is still an
underestimated condition, even in neurology practice
[22,23]. Thus it can easily be missed in adolescents, as
well as the adults. In order to maintain a successful
school performance, primary care physicians should be
aware of the probability of migraine headaches [24]. ID
Migraine™ test, being a useful, valid and quick screen-
ing tool, will help primary care physicians in order to
diagnose migraine in adolescents as well.
Figure 2 Participants according to age groups.
Table 1 Headache group according to gender
Did you have two or more headaches in the last 3 months?
Yes No Total
Male 706 (19.1%) 1144 (31.0%) 1850 (50.1%)
Female 907 (24.6%) 937 (25.3%) 1844 (49.9%)
Total 1613 (43.7%) 2081 (56.3%) 3694 (100.0%)
Pearson c
2 = 45.628, p < 0.001.
Table 2 Comparison between adolescent and adult age
groups
Id-Migraine™ results
Migrainous Non-
Migrainous
Total
Adolescent (≤19 years of
age)
183 (7.0%) 2450 (93.0%) 2633
(100%)
Adult (>19 years of age) 83 (7.8%) 978 (92.2%) 1061
(100%)
Total 266 3428 3694
Pearson c
2 = 0.862, p = 0.353.
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Table 3 Migraine prevalence according to gender and
age
Positive ID-Migraine test
n%p
Gender Male 72 3.9 Pearson c
2=
Female 194 10.5 60.725,
Total 266 7.2 p < 0.001
Age 17-19 yrs. 183 7.0 Pearson c
2=
20-24 yrs. 75 7.7 0.862,
25-37 yrs. 8 9.9 p = 0.493
Total 266 7.2
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